Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure

Günay Yetik Anacak, Levent Üstünes, Ozlem Yilmaz Dilsiz, Adviye Ergul

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The antiatherosclerotic effect of lacidipine has been attributed to its actions on cholesterol levels, lipid metabolism or oxidant stress in advanced disease. The purpose of the present experiments was to examine whether lacidipine is protective of intimal thickening and vascular dysfunction in early atherosclerosis in the absence of the hypertension and hypercholesterolemia. A second goal was to determine whether and to what extent MMP-9 and oxidant stress are involved in possible beneficial effects of lacidipine. Lacidipine treatment (5. mg/kg/day, p.o. for 3. weeks) significantly prevented the collar-induced intimal thickening. MMP-9 expressions were increased by collar but not effected by lacidipine treatment. Nitrotyrosine staining, a marker for oxidant stress was not changed neither by collar nor lacidipine treatment in early atherosclerosis. The enhanced sensitivity to serotonine and diminished sensitivity to acetylcholine in collared arteries were restored to normal levels with treatment. These results demonstrate that the lacidipine treatment prevents the collar-induced intimal thickening and accompanying vascular dysfunction in early atherosclerosis without cholesterol loading. These beneficial effects of lacidipine were not associated with changes in either MMP-9 expression or oxidant stress. However, enhanced endothelium-dependent relaxations by lacidipine, suggest that vascular protective effects of nitric oxide may be at least partly, responsible from antiatherosclerotic effects of lacidipine.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalVascular Pharmacology
Volume53
Issue number5-6
DOIs
StatePublished - Nov 1 2010

Fingerprint

Lipid Metabolism
Blood Pressure
Tunica Intima
Oxidants
Matrix Metalloproteinases
Blood Vessels
Atherosclerosis
Cholesterol
lacidipine
Hypercholesterolemia
Acetylcholine
Endothelium
Nitric Oxide
Arteries
Staining and Labeling
Hypertension

Keywords

  • 5-HT sensitivity
  • Collar-induced atherosclerosis
  • Intimal thickening
  • Lacidipine
  • MMP-9
  • Nitric oxide
  • Rabbit carotid artery
  • Vascular reactivity

ASJC Scopus subject areas

  • Physiology
  • Molecular Medicine
  • Pharmacology

Cite this

Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. / Yetik Anacak, Günay; Üstünes, Levent; Dilsiz, Ozlem Yilmaz; Ergul, Adviye.

In: Vascular Pharmacology, Vol. 53, No. 5-6, 01.11.2010, p. 193-199.

Research output: Contribution to journalArticle

Yetik Anacak, Günay ; Üstünes, Levent ; Dilsiz, Ozlem Yilmaz ; Ergul, Adviye. / Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. In: Vascular Pharmacology. 2010 ; Vol. 53, No. 5-6. pp. 193-199.
@article{62f5b66297d8428798b62aeecbdb3beb,
title = "Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure",
abstract = "The antiatherosclerotic effect of lacidipine has been attributed to its actions on cholesterol levels, lipid metabolism or oxidant stress in advanced disease. The purpose of the present experiments was to examine whether lacidipine is protective of intimal thickening and vascular dysfunction in early atherosclerosis in the absence of the hypertension and hypercholesterolemia. A second goal was to determine whether and to what extent MMP-9 and oxidant stress are involved in possible beneficial effects of lacidipine. Lacidipine treatment (5. mg/kg/day, p.o. for 3. weeks) significantly prevented the collar-induced intimal thickening. MMP-9 expressions were increased by collar but not effected by lacidipine treatment. Nitrotyrosine staining, a marker for oxidant stress was not changed neither by collar nor lacidipine treatment in early atherosclerosis. The enhanced sensitivity to serotonine and diminished sensitivity to acetylcholine in collared arteries were restored to normal levels with treatment. These results demonstrate that the lacidipine treatment prevents the collar-induced intimal thickening and accompanying vascular dysfunction in early atherosclerosis without cholesterol loading. These beneficial effects of lacidipine were not associated with changes in either MMP-9 expression or oxidant stress. However, enhanced endothelium-dependent relaxations by lacidipine, suggest that vascular protective effects of nitric oxide may be at least partly, responsible from antiatherosclerotic effects of lacidipine.",
keywords = "5-HT sensitivity, Collar-induced atherosclerosis, Intimal thickening, Lacidipine, MMP-9, Nitric oxide, Rabbit carotid artery, Vascular reactivity",
author = "{Yetik Anacak}, G{\"u}nay and Levent {\"U}st{\"u}nes and Dilsiz, {Ozlem Yilmaz} and Adviye Ergul",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.vph.2010.08.003",
language = "English (US)",
volume = "53",
pages = "193--199",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "5-6",

}

TY - JOUR

T1 - Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure

AU - Yetik Anacak, Günay

AU - Üstünes, Levent

AU - Dilsiz, Ozlem Yilmaz

AU - Ergul, Adviye

PY - 2010/11/1

Y1 - 2010/11/1

N2 - The antiatherosclerotic effect of lacidipine has been attributed to its actions on cholesterol levels, lipid metabolism or oxidant stress in advanced disease. The purpose of the present experiments was to examine whether lacidipine is protective of intimal thickening and vascular dysfunction in early atherosclerosis in the absence of the hypertension and hypercholesterolemia. A second goal was to determine whether and to what extent MMP-9 and oxidant stress are involved in possible beneficial effects of lacidipine. Lacidipine treatment (5. mg/kg/day, p.o. for 3. weeks) significantly prevented the collar-induced intimal thickening. MMP-9 expressions were increased by collar but not effected by lacidipine treatment. Nitrotyrosine staining, a marker for oxidant stress was not changed neither by collar nor lacidipine treatment in early atherosclerosis. The enhanced sensitivity to serotonine and diminished sensitivity to acetylcholine in collared arteries were restored to normal levels with treatment. These results demonstrate that the lacidipine treatment prevents the collar-induced intimal thickening and accompanying vascular dysfunction in early atherosclerosis without cholesterol loading. These beneficial effects of lacidipine were not associated with changes in either MMP-9 expression or oxidant stress. However, enhanced endothelium-dependent relaxations by lacidipine, suggest that vascular protective effects of nitric oxide may be at least partly, responsible from antiatherosclerotic effects of lacidipine.

AB - The antiatherosclerotic effect of lacidipine has been attributed to its actions on cholesterol levels, lipid metabolism or oxidant stress in advanced disease. The purpose of the present experiments was to examine whether lacidipine is protective of intimal thickening and vascular dysfunction in early atherosclerosis in the absence of the hypertension and hypercholesterolemia. A second goal was to determine whether and to what extent MMP-9 and oxidant stress are involved in possible beneficial effects of lacidipine. Lacidipine treatment (5. mg/kg/day, p.o. for 3. weeks) significantly prevented the collar-induced intimal thickening. MMP-9 expressions were increased by collar but not effected by lacidipine treatment. Nitrotyrosine staining, a marker for oxidant stress was not changed neither by collar nor lacidipine treatment in early atherosclerosis. The enhanced sensitivity to serotonine and diminished sensitivity to acetylcholine in collared arteries were restored to normal levels with treatment. These results demonstrate that the lacidipine treatment prevents the collar-induced intimal thickening and accompanying vascular dysfunction in early atherosclerosis without cholesterol loading. These beneficial effects of lacidipine were not associated with changes in either MMP-9 expression or oxidant stress. However, enhanced endothelium-dependent relaxations by lacidipine, suggest that vascular protective effects of nitric oxide may be at least partly, responsible from antiatherosclerotic effects of lacidipine.

KW - 5-HT sensitivity

KW - Collar-induced atherosclerosis

KW - Intimal thickening

KW - Lacidipine

KW - MMP-9

KW - Nitric oxide

KW - Rabbit carotid artery

KW - Vascular reactivity

UR - http://www.scopus.com/inward/record.url?scp=78349308923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349308923&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2010.08.003

DO - 10.1016/j.vph.2010.08.003

M3 - Article

C2 - 20709189

AN - SCOPUS:78349308923

VL - 53

SP - 193

EP - 199

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 5-6

ER -